Horsa Boressa Adugna, Ayele Yohanes, Ayalew Mohammed Biset
Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Department of Clinical Pharmacy, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
SAGE Open Med. 2019 Feb 2;7:2050312119827409. doi: 10.1177/2050312119827409. eCollection 2019.
Critically ill patients with moderate-to-severe physiologically stressful event are at high risk of developing stress ulcers. The use of pharmacological prophylaxis significantly reduces the incidence of stress ulcer in high-risk patients.
The aim of this study was to assess the use of pharmacological prophylaxis for stress ulcer in the medical wards of University of Gondar Hospital.
A cross-sectional study design was used. In total, 234 patients were selected through simple random sampling technique. The risk of stress ulcer development was assessed using Evidence-Based Medicine Guideline for stress ulcer prepared by Orlando Regional Medical Center. SPSS version 21 was used for data analysis.
The most common acute risk factor to stress ulcer was coagulopathy (18.4%), followed by hypoperfusion (9.8%). The concomitant non-steroidal anti-inflammatory drug use (16.7%), mild-to-moderate brain or spinal cord injury (11.1%), and concomitant or recent corticosteroid use (9.4%) were frequently seen risk factors that necessitate administration of a prophylaxis. In total, 82 (35%) study participants were given stress ulcer prophylaxis, among which 52 (63.4%) were given without indication. The most commonly used drug class in the prevention of stress ulcer was proton pump inhibitors (76/82, 92.7%). In total, 43 (18.4%) study subjects were not given stress ulcer prophylaxis while there was clear indication. Patients with a long hospital stay and a diagnosis of central nervous system disorders had significant risk for inappropriate stress ulcer prophylaxis use.
In this study, inappropriate use of prophylaxis for stress ulcer was common. The higher proportion of inappropriateness was due to the use of stress ulcer prophylaxis while there was no enough indication. We recommend future researchers to assess the cost and impact of inappropriate stress ulcer prophylaxis use, and the physicians should be adherent to the standard guidelines.
患有中度至重度生理应激事件的重症患者发生应激性溃疡的风险很高。使用药物预防可显著降低高危患者应激性溃疡的发生率。
本研究旨在评估贡德尔大学医院内科病房对应激性溃疡的药物预防使用情况。
采用横断面研究设计。通过简单随机抽样技术共选取234例患者。使用奥兰多地区医疗中心制定的应激性溃疡循证医学指南评估发生应激性溃疡的风险。采用SPSS 21版进行数据分析。
应激性溃疡最常见的急性危险因素是凝血功能障碍(18.4%),其次是灌注不足(9.8%)。常见的需要进行预防的危险因素包括同时使用非甾体抗炎药(16.7%)、轻度至中度脑或脊髓损伤(11.1%)以及同时或近期使用皮质类固醇(9.4%)。共有82例(35%)研究参与者接受了应激性溃疡预防,其中52例(63.4%)是在无指征的情况下给予的。预防应激性溃疡最常用的药物类别是质子泵抑制剂(76/82,92.7%)。共有43例(18.